+ Follow ADENOMA PREVENTION Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 72541
[Title] => Celecoxib protects against colorectal adenoma 2 years out
[Summary] =>
[DatePublished] => 2008-07-13 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[1] => Array
(
[ArticleID] => 390057
[Title] => Halted trials: Celecoxib tied to rise in CV risk
[Summary] => Celecoxib cannot be recommended to reduce colorectal cancer risk  despite its proven efficacy for that indication  until more is known about its potential cardiovascular risks, coordinators of two chemoprevention trials concluded.
[DatePublished] => 2007-03-18 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
ADENOMA PREVENTION
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 72541
[Title] => Celecoxib protects against colorectal adenoma 2 years out
[Summary] =>
[DatePublished] => 2008-07-13 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[1] => Array
(
[ArticleID] => 390057
[Title] => Halted trials: Celecoxib tied to rise in CV risk
[Summary] => Celecoxib cannot be recommended to reduce colorectal cancer risk  despite its proven efficacy for that indication  until more is known about its potential cardiovascular risks, coordinators of two chemoprevention trials concluded.
[DatePublished] => 2007-03-18 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
abtest